Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China 2018-08-09 17:05
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes 2018-08-09 16:16
TOT BIOPHARM raises US$102 million in Series B Financing Round 2018-08-08 19:00
VolitionRx Announces $9 Million Private Placement 2018-08-08 18:00
I-Mab Biopharma and MorphoSys Announce China IND Submission of TJ202/MOR202 2018-08-08 09:01
Ward MM and Adapt Analytics announce a partnership to integrate AI and machine learning into Ward MM's clinical decision support engine 2018-08-07 21:00
Adlai Nortye Announces Engagement of Lars E. Birgerson, M.D., Ph.D., as CDO and President/CEO of Adlai Nortye USA 2018-08-07 01:15
China Biologic Reports Financial Results for the Second Quarter of 2018 2018-08-04 04:30
IMPACT Therapeutics Raises $30 Million In Series C Financing 2018-08-03 16:48
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA 2018-08-01 18:52
I-Mab Biopharma Announces New CFO 2018-08-01 08:44
WuXi Biologics Commenced Process Validation in MFG2 2018-07-31 07:55
CStone's MEK Inhibitor CS3006 Receives IND Approval in China 2018-07-30 12:51
China Biologic Products to Report Second Quarter 2018 Financial Results 2018-07-27 20:00
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-045, a Potent ALDH2 Activator 2018-07-26 19:30
WuXi STA's Jinshan Site Passes Fourth U.S. FDA Inspection 2018-07-26 08:00
OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing 2018-07-23 14:42
Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China 2018-07-22 22:11
Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia 2018-07-19 21:00
China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing 2018-07-17 19:00
1 138 139 140 141 142 165